" we then could easily see 300+ plus upfront money and 30-50 percent royality split if we go that route"
What other compound have you seen get $300 million (+) upfront with a 30-50% royalty split? Is this real analysis of other pharma compounds or just wild speculation?
I can tell you one thing: Ariad will never get $300 million upfront from ANY ONE COMPOUND. That's pretty much guaranteed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.